Financial News
Gilead's revenue rises 17% driven by sales of coronavirus treatment remdesivir
October 28, 2020 at 17:11 PM EDT
Remdesivir generated $873 million in sales during the third quarter, mostly in the U.S., the company said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
